Sova Pharmaceuticals, Inc. logo

Sova Pharmaceuticals, Inc.

Sova Pharmaceuticals, is a biopharmaceutical company engaged in the discovery and development of small therapeutics for the treatment of inflammatory and neuropathic pain.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.sovapharma.com
Founded2010
Disease Focus
Development Stage
STOCK CODENon Listed
Address
11099 North Torrey Pines Road, Suite 290, CA, 92037
La Jolla
United States
Email
Contact Number
+1 858-750-4700

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/sova-pharmaceuticals-inc.” connections=”true” suffix=””]

The Companys Technology is based on modulation of cystathionine-?-lyase (CSE), a novel enzymatic target involved in the production of hydrogen sulfide(H2S), which imparts a multi-modal effect across various ion channels involved in nociception and signal transmission.

Avlon Ventures provided an Undisclosed funding to Sova pharmaceuticals for the development of therapeutics to treat central sleep apnea. Also, ResMed Inc., provided a undisclosed funding to Sova Pharmaceuticals.